SecBot SecBot
Insider Cluster (4 insiders) ·Filed Aug 17, 2026

EDAP

EDAP TMS SA
MIXED
Impact 5/10
Horizondays Processed3mo ago
Insider cluster: 3 insiders, $0.1M total
Actionable Insight ◆ Mixed

The insider buying at the offering price is a modest positive signal, but the small dollar amount (<0.1% of market cap) and proximity to a 22.5% dilutive offering limit conviction. Monitor for any subsequent Form 4 filings from additional insiders or follow-on buying; the FOCL Q2 earnings (strong revenue growth but widening losses) should be the primary driver of near-term price action.

DirectionMixed
Confidencemedium
Horizondays

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Four insiders, including CFO Kenneth Mobeck, SVP Steven Annen, and directors Joshua Levine and David Horn, purchased a total of $142,500 in EDAP ADSs at $4.75 per ADS on August 14, 2026. These open-market buys occurred on the same day as the closing of a dilutive $40M public offering priced at $4.75, suggesting insiders view the post-dilution stock price as attractive, but the cluster is small relative to the company's market cap.

Key Financial Metrics

Direction
buying
Total Value
$142.5K
Insiders
4

Key Facts

  • CFO Kenneth Mobeck purchased 5,000 ADSs for $23,750.
  • SVP Steven Annen purchased 5,000 ADSs for $23,750.
  • Directors Joshua Levine and David Horn each purchased 10,000 ADSs for $47,500.
  • All purchases were executed at $4.75 per ADS on the closing date of the $40M public offering.
  • The total $142,500 in open-market purchases represents approximately <0.1% of the company's market cap (~$326M).
  • The public offering sold 8,425,000 ADSs plus overallotment option, representing ~22.5% dilution.

Financial Impact

Insider purchases total $142,500 at $4.75/share, against a $40M dilutive offering (22.5% dilution).

dilutioninsider ownership

Risk Factors

  • The $40M offering dilutes existing shareholders by ~22.5%, offsetting insider confidence signal.
  • The company's net loss widened to $14.4M in Q2 2026, raising cash-burn concerns.
  • Insider purchases at $4.75 may simply represent insiders maintaining pro-rata ownership to avoid dilution, not a bullish price signal.

Market Snapshot

Exchange
Nasdaq
Sector
Electromedical & Electrotherapeutic Apparatus
Analyst Consensus
67% bullish (9 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-EDAP-1787033446923

US Market Status

Market Closed · Opens Wed (10h)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 18, 2026